2019. Sep

Characterization of a novel LQT3 variant with a selective efficacy of mexiletine treatment.

Sci Rep. 2019

Kim HJ, Kim BG, Park JE, Ki CS, Huh J, Youm JB, Kang JS, Cho H.

Privacy Policy
Terms of Use

Green Cross Genome Corporation I  Representative: KI CHANG SEOK   I   Business Registration No. 142-81-61687

107, Ihyeon-ro 30beon-gil, Giheung-gu, Yongin-si, Gyeonggi-do, 16924, Korea

Email. info@gcgenome.com  I  Tel. +82 31-280-9939   I    Fax. +82 31-260-9087

©2021 by GC Genome.